Hyderabad-based Hetero gets DCGI nod to manufacture, market Molnupiravir capsules
New Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreNew Delhi: Hyderabad-based pharmaceuticals firm Hetero Tuesday said it has received permission from the Drug Controller General of India (DCGI) ...
Read moreHyderabad: Hetero, one of India's leading generic pharmaceutical companies and the world's largest producer of antiretroviral drugs, on Wednesday announced ...
Read moreNew Delhi: Four domestic pharma firms – Cipla, Jubilant Life Sciences, Hetero and Mylan – have entered into non-exclusive licensing agreements ...
Read more
The Union government says that the “Indian Census is the largest single source of various statistical information on various characteristics...
Read moreWith the AAP’s dramatic downfall and the BJP’s resounding victory, Delhi’s civil servants finally seem to be breathing easy. Having...
Read moreI was fortunate to participate in the recent AI Action Summit in Paris, where many discussions emphasized the need to...
Read moreWith only a few weeks to go before the federal election on 23 February, Germany experienced a political earthquake. For...
Read more